(Q45863664)

17 December 2017

title

Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritis (English)

1 reference

17 December 2017

0 references

0 references

Smith R

1

1 reference

17 December 2017

Tarner IH

2

1 reference

17 December 2017

Hollenhorst M

3

1 reference

17 December 2017

Lin C

4

1 reference

17 December 2017

Levicnik AU

5

1 reference

17 December 2017

Fathman CG

6

1 reference

17 December 2017

Nolan GP

7

1 reference

17 December 2017

publication date

1 August 2003

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

10

1 reference

17 December 2017

issue

15

1 reference

17 December 2017

page(s)

1248-1257

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301980

exact match

0 references

cites work

Cytokines induce the development of functionally heterogeneous T helper cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Role of cytokines in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

TNF alpha is an effective therapeutic target for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Infliximab: a review of its use in the management of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

The application of gene therapy in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Gene therapy in the treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Gene therapy in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Intracellular immunization with cytosolic recombinant antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Inhibition of signaling from Type 1 receptor tyrosine kinases via intracellular expression of single-chain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

7 January 2021

Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

7 January 2021

Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

7 January 2021

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

7 January 2021

Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

7 January 2021

The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

7 January 2021

Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301980

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301980

1 reference

17 December 2017

Dimensions Publication ID

1041518133

0 references

1 reference

17 December 2017